18.4
Unicycive Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
2.64
FY23:
13.4
FY24:
30.9
FY25:
49.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.33
FY22:
0.17
FY23:
0.79
FY24:
0.72
FY25:
0.17
Total assets
Change from FY21 to FY25
millions USD
FY21:
18.7
FY22:
2.82
FY23:
14.2
FY24:
31.7
FY25:
49.1
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
2.11
FY22:
3.28
FY23:
17.5
FY24:
24.1
FY25:
18.9
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.16
FY22:
0
FY23:
0.47
FY24:
0.12
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
16.5
FY22:
−0.47
FY23:
−3.81
FY24:
7.43
FY25:
30.2
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
18.7
FY22:
2.82
FY23:
14.2
FY24:
31.7
FY25:
49.1
All amounts in millions USD